CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model

BACKGROUND: GPRC6A is implicated in the pathogenesis of prostate cancer, but its role remains uncertain because of a purported tolerant gene variant created by substitution of a K..Y polymorphism in the 3rd intracellular loop (IL) that evolved in the majority of humans and replaces the ancestral RKL...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ruisong, Pi, Min, Cox, John V., Nishimoto, Satoru K., Quarles, L. Darryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490090/
https://www.ncbi.nlm.nih.gov/pubmed/28659174
http://dx.doi.org/10.1186/s13046-017-0561-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490090/
https://www.ncbi.nlm.nih.gov/pubmed/28659174
http://dx.doi.org/10.1186/s13046-017-0561-x

Ejemplares similares